Pro Medicus Limited
PME
Rang in aandelen
#1598
Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a... Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a leading provider of medical imaging software and services. The company develops and delivers advanced solutions to hospitals, diagnostic imaging groups, and other healthcare organizations across Australia, North America, and Europe. Their core offerings include proprietary Radiology Information Systems (RIS), which streamline practice management and come with comprehensive support, training, installation, and professional services. Pro Medicus also operates Promedicus.net, an e-health platform, and supplies sophisticated imaging software designed to provide radiologists and clinicians with powerful visualization capabilities for 2D, 3D, and 4D medical images. This suite of tools is further enhanced by Picture Archiving and Communication System (PACS)/digital imaging software and integration products. Additionally, they offer mobile applications like Visage Ease Pro, which enables remote interpretation of diagnostic imaging studies stored on a Visage 7 server. Key product brands include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease.
Aandeelprijs
$129.30
Marktkapitalisatie
$13.51B
Verandering (1 dag)
-0.17%
Verandering (1 jaar)
-30.83%
Land
AU
Handel Pro Medicus Limited (PME)
Categorie
Healthcare
Winst voor Pro Medicus Limited (PME)
Winst in Jun 2026 TTM: $266.26M
Volgens de meest recente financiële verslagen van Pro Medicus Limited bedraagt de huidige winst van het bedrijf $266.26M. In 2024 behaalde het bedrijf een winst van $77.79M, een stijging ten opzichte van de winst van 2023, die $57.38M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Pro Medicus Limited van 2000 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $266.26M | 147.66% |
| 2025 | $107.51M | 38.21% |
| 2024 | $77.79M | 35.55% |
| 2023 | $57.38M | 31.89% |
| 2022 | $43.51M | 35.35% |
| 2021 | $32.15M | 55.19% |
| 2020 | $20.71M | 12.91% |
| 2019 | $18.35M | 61.89% |
| 2018 | $11.33M | 9.72% |
| 2017 | $10.33M | 45.98% |
| 2016 | $7.07M | 79.75% |
| 2015 | $3.94M | 70.17% |
| 2014 | $2.31M | -151.63% |
| 2013 | $-4.48M | -530.12% |
| 2012 | $1.04M | 38.76% |
| 2011 | $750.57K | -84.46% |
| 2010 | $4.83M | -24.83% |
| 2009 | $6.42M | -40.86% |
| 2008 | $10.86M | 31.35% |
| 2007 | $8.27M | 29.34% |
| 2006 | $6.39M | 9.18% |
| 2005 | $5.86M | 68.01% |
| 2004 | $3.49M | -19.23% |
| 2003 | $4.32M | 13.36% |
| 2002 | $3.81M | 19.88% |
| 2001 | $3.18M | 2.97% |
| 2000 | $3.08M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $2.04B | 667.30% |
US
|
|
| $295.53M | 11.00% |
US
|
|
| $-259.89M | -197.61% |
US
|
|
| $-74.89M | -128.13% |
US
|
|
| - | - |
US
|
